pe.onwuka
TL2 Moderator · Funchal
Contributes reviews on supplier material. Based in Funchal.
Joined 15 November 2024 · last posted 1d
93 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #43 · Clinical › Bloodwork · 27 Jul 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #82 · Practice › Dosing & titration · 20 Jul 2026 · 0 likes On post #78 — agreed on the reasoning, with one qualification. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #82 · Meta › Announcements · 13 Jul 2026 · 2 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #8 · Practice › Interactions · 9 Jul 2026 · 10 likes This follows post #5 rather than contradicting it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes…
-
Prescription requirements and telehealth models — a second dataset Replied, post #94 · Sourcing › Regulatory · 6 Jul 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Naming conventions for research peptides and the confusion they cause Replied, post #26 · Compounds › Other compounds · 6 Jul 2026 · 26 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #27 · Evidence › Journal club · 5 Jul 2026 · 32 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Prescription portability between countries Replied, post #76 · Access › International · 25 Jun 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #82 · Safety › Contraindications · 21 Jun 2026 · 13 likes On post #78 — agreed on the reasoning, with one qualification. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication…
-
Packaging that arrived damaged: documenting it properly Replied, post #28 · Sourcing › Logistics · 20 Jun 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #20 · Pharmacology › Receptor biology · 17 Jun 2026 · 3 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #32 · Pharmacology › Formulation chemistry · 17 Jun 2026 · 31 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold? Started this topic · Analytics › Mass spectrometry · 13 Jun 2026 · 29 likes Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold? — that is the question, and I have not found it answered plainly anywhere I…
-
Injecting into an area that has become firm: why not to Replied, post #38 · Practice › Administration · 9 Jun 2026 · 0 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #54 · Compounds › Semaglutide · 7 Jun 2026 · 8 likes post #53 answers the question as asked. The question underneath it is different. The SELECT trial changed the positioning because it was the first cardiovascular…
-
Reading a trial's population section before its results Replied, post #94 · Evidence › Trials · 6 Jun 2026 · 19 likes Picking up post #91: that is the part I would want checked first. Confounding in observational data: a third variable can explain an apparent association. In a…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #31 · Evidence › Journal club · 31 May 2026 · 22 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Reading a trial's population section before its results Replied, post #71 · Evidence › Trials · 31 May 2026 · 21 likes I read post #69 twice before replying, because I had assumed the opposite. The estimand: what the trial set out to estimate. Two trials can be identical in structure…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #101 · Compounds › Tirzepatide · 29 May 2026 · 5 likes post #100 answers the question as asked. The question underneath it is different. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #30 · Compounds › Tirzepatide · 7 May 2026 · 29 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #107 · Practice › Reconstitution · 4 May 2026 · 0 likes post #106 is right about the mechanism and I think understates the practical bit. How much of the diluent volume the powder itself displaces: for a small peptide vial,…
-
A fridge failure and how I assessed the contents afterwards Replied, post #8 · Devices › Cold chain · 23 Apr 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #28 · Devices › Syringes & needles · 13 Apr 2026 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #37 · Evidence › Journal club · 12 Apr 2026 · 4 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #21 · Practice › Interactions · 5 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Preprint servers and what screening they do Replied, post #106 · Evidence › Preprints · 28 Mar 2026 · 0 likes I read post #104 twice before replying, because I had assumed the opposite. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #108 · Lounge › Introductions · 19 Mar 2026 · 0 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #7 · Evidence › Journal club · 13 Mar 2026 · 5 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #6 · Evidence › Journal club · 9 Mar 2026 · 21 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
MHRA statements, read directly Replied, post #97 · Regional › UK & Ireland · 26 Feb 2026 · 2 likes This follows post #94 rather than contradicting it. Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and…
-
Dead volume across syringe and needle combinations Replied, post #76 · Devices › Syringes & needles · 21 Feb 2026 · 26 likes This follows post #73 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Adolescents: a distinct evidence base — one year on Replied, post #65 · Clinical › Special populations · 16 Feb 2026 · 5 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #48 · Data & Tools › Calculators · 15 Feb 2026 · 23 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #22 · Practice › Interactions · 14 Feb 2026 · 2 likes Coming back to post #20, because the follow-up matters more than the original answer. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
Reading an interaction checker output critically Replied, post #118 · Practice › Interactions · 12 Feb 2026 · 30 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Cost per delivered dose, which is the number that matters Replied, post #46 · Access › Pricing · 7 Feb 2026 · 32 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #56 · Compounds › Semaglutide · 16 Jan 2026 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #15 · Practice › Side effects · 13 Jan 2026 · 0 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
A partial dose because the pen emptied mid-injection Replied, post #20 · Practice › Administration · 7 Jan 2026 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #67 · Practice › Interactions · 12 Dec 2025 · 18 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #33 · Pharmacology › Pharmacokinetics · 7 Dec 2025 · 4 likes Picking up post #30: that is the part I would want checked first. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours.…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #79 · Practice › Reconstitution · 9 Nov 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #9 · Sourcing › Regulatory · 30 Oct 2025 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #105 · Analytics › HPLC & UHPLC · 13 Oct 2025 · 0 likes Worth separating two things that post #101 runs together. On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram…
-
New subcategory: rationale and scope Replied, post #11 · Meta › Announcements · 12 Oct 2025 · 20 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
What a purity-only report leaves out Replied, post #44 · Sourcing › Independent verification · 12 Oct 2025 · 0 likes Coming back to post #42, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #5 · Start Here › Welcome · 11 Oct 2025 · 0 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #74 · Practice › Reconstitution · 7 Oct 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Gauge and length selection for subcutaneous injection Replied, post #37 · Devices › Syringes & needles · 7 Oct 2025 · 24 likes post #36 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #4 · Compounds › Semaglutide · 3 Oct 2025 · 1 like Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #44 · Pharmacology › Receptor biology · 25 Sep 2025 · 1 like Picking up post #41: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Payment method and the leverage it gives you, ranked Replied, post #44 · Sourcing › Payments · 20 Sep 2025 · 17 likes I read post #42 twice before replying, because I had assumed the opposite. Refund policy before ordering: ask what the policy is if you receive damaged material or if…
-
Second pass at: Programming during a large energy deficit Replied, post #6 · Nutrition & Training › Resistance training · 12 Sep 2025 · 0 likes Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #87 · Evidence › Journal club · 8 Sep 2025 · 30 likes Picking up post #84: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #22 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes This follows post #19 rather than contradicting it. Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #36 · Practice › Side effects · 16 Aug 2025 · 1 like Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Coming back to: When "no data" is the complete and final answer Replied, post #83 · Compounds › Other compounds · 13 Aug 2025 · 11 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Travel coolers and how long they really hold Replied, post #76 · Devices › Cold chain · 7 Aug 2025 · 0 likes Picking up post #73: that is the part I would want checked first. Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day…
-
When a preprint is the best available evidence and we say so Replied, post #27 · Evidence › Preprints · 5 Aug 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A ten-fold dose error caught before injection — one year on Replied, post #6 · Devices › Syringes & needles · 31 Jul 2025 · 12 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2025 · 16 likes post #28 answers the question as asked. The question underneath it is different. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
Cagrilintide molecular characteristics and analytical considerations Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
An emergency department visit, described afterwards Replied, post #41 · Safety › Adverse events · 12 Jul 2025 · 7 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #29 · Devices › Syringes & needles · 19 Jun 2025 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Aspirating before injection: for subcutaneous injection, aspirating (pulling back…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #38 · Evidence › Journal club · 14 Jun 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Antibiotics and a course of something with delayed emptying Replied, post #63 · Practice › Interactions · 12 Jun 2025 · 28 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #65 · Access › Insurance & coverage · 11 Jun 2025 · 33 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Half-life, steady state, and accumulation worked through Replied, post #56 · Pharmacology › Pharmacokinetics · 2 Jun 2025 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Pre-registering a personal experiment, seriously Replied, post #91 · Research Methods › N-of-1 designs · 2 Jun 2025 · 24 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #117 · Evidence › Journal club · 15 May 2025 · 15 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Follow-up: What other technical communities get right that we do not Replied, post #75 · Lounge › Off topic · 22 Apr 2025 · 18 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #87 · Evidence › Journal club · 21 Apr 2025 · 5 likes post #86 is right about the mechanism and I think understates the practical bit. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #62 · Evidence › Journal club · 20 Apr 2025 · 23 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Reading order for a first week here, and what to skip until later Replied, post #82 · Start Here › Welcome · 14 Apr 2025 · 11 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #48 · Sourcing › Vendor reports · 2 Apr 2025 · 25 likes post #47 is right about the mechanism and I think understates the practical bit. Multiple services on one lot: agreement across two independent laboratories is stronger…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #84 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 4 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 20 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #95 · Analytics › COA interpretation · 18 Mar 2025 · 2 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #31 · Practice › Reconstitution · 14 Mar 2025 · 13 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #93 · Data & Tools › Calculators · 16 Feb 2025 · 27 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A page that has drifted out of date and needs a maintainer Replied, post #58 · Documentation › Wiki requests · 31 Jan 2025 · 0 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #18 · Sourcing › Vendor reports · 28 Dec 2024 · 7 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #127 · Practice › Dosing & titration · 16 Dec 2024 · 5 likes post #126 is right about the mechanism and I think understates the practical bit. How the published trials escalated: they used specific step sizes and intervals. The…
-
What we do not know about retatrutide, listed explicitly Replied, post #14 · Compounds › Retatrutide · 7 Dec 2024 · 11 likes On post #10 — agreed on the reasoning, with one qualification. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #86 · Compounds › Repair & healing peptides · 18 Nov 2024 · 27 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Time to steady state after a dose increase Replied, post #46 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 14 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
When "no data" is the complete and final answer Replied, post #3 · Compounds › Other compounds · 12 Oct 2024 · 0 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
When a red flag was a misunderstanding, and the retraction Replied, post #30 · Sourcing › Red flags · 8 Oct 2024 · 2 likes Coming back to post #28, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Blind submission and why it changes minds Replied, post #74 · Sourcing › Independent verification · 29 Sep 2024 · 4 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #39 · Evidence › Journal club · 10 Sep 2024 · 0 likes I read post #37 twice before replying, because I had assumed the opposite. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
-
Gradient steepness and apparent purity: a worked comparison Started this topic · Analytics › HPLC & UHPLC · 8 Jul 2024 · 0 likes On the subject in the title: Gradient steepness and apparent purity: a worked comparison Working notes rather than a conclusion. A documentation question rather than an…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #20 · Practice › Dosing & titration · 29 Jun 2024 · 17 likes On post #16 — agreed on the reasoning, with one qualification. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological…
-
Assessing a warm arrival: the decision process — one year on Replied, post #124 · Sourcing › Logistics · 2 Jun 2024 · 1 like At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…